Zhengye Biotechnology Holding (ZYBT) Construction in Progress (2023 - 2025)
Zhengye Biotechnology Holding has reported Construction in Progress over the past 3 years, most recently at $86005.5 for Q4 2025.
- Quarterly Construction in Progress fell 93.67% to $86005.5 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86005.5 through Dec 2025, down 93.67% year-over-year, with the annual reading at $87000.0 for FY2025, 93.49% down from the prior year.
- Construction in Progress was $86005.5 for Q4 2025 at Zhengye Biotechnology Holding, down from $1.4 million in the prior quarter.
- Over five years, Construction in Progress peaked at $1.4 million in Q4 2024 and troughed at $86005.5 in Q4 2025.
- The 3-year median for Construction in Progress is $1.1 million (2023), against an average of $833801.2.
- Year-over-year, Construction in Progress rose 28.35% in 2024 and then plummeted 93.67% in 2025.
- A 3-year view of Construction in Progress shows it stood at $1.1 million in 2023, then increased by 28.35% to $1.4 million in 2024, then plummeted by 93.67% to $86005.5 in 2025.
- Per Business Quant, the three most recent readings for ZYBT's Construction in Progress are $86005.5 (Q4 2025), $1.4 million (Q4 2024), and $1.1 million (Q4 2023).